Nutraplus India Ltd

Nutraplus India Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Nutraplus India Ltd

₹ 2.10 5.00%
13 Dec 2021
nutraplusindia.com BSE: 524764
About

Nutraplus India is engaged in the Business of Drugs and Pharmaceuticals.

[ add key points ]
Website BSE
  • Market Cap ₹ 7.16 Cr.
  • Current Price ₹ 2.10
  • High / Low ₹ /
  • Stock P/E
  • Book Value ₹ -0.60
  • Dividend Yield 0.00 %
  • ROCE -0.53 %
  • ROE -2.04 %
  • Face Value ₹ 5.00
Edit ratios

Pros

  • Company has reduced debt.

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -80.8% over past five years.
  • Company has a low return on equity of -36.2% over last 3 years.
  • Company might be capitalizing the interest cost
  • Company has high debtors of 19,710 days.
  • Company's cost of borrowing seems high

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017 Jun 2017 Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020
23 16 25 31 35 29 32 43 36 32 39 22 14
26 16 21 28 32 25 27 40 34 29 36 35 43
Operating Profit -3 0 3 3 3 3 5 3 2 3 3 -13 -29
OPM % -12% 1% 13% 11% 8% 12% 14% 7% 4% 9% 9% -58% -214%
0 0 0 0 0 0 0 0 2 0 0 0 0
Interest 1 2 2 2 -1 2 2 2 1 2 2 2 1
Depreciation 1 1 1 1 1 1 1 1 1 1 1 1 1
Profit before tax -4 -3 0 0 3 0 1 0 2 0 0 -16 -32
Tax % 38% 0% 0% 0% 22% 0% 0% 0% 69% 0% 0% -0% 0%
-3 -3 0 0 3 0 1 0 1 0 0 -16 -32
EPS in Rs -0.82 -0.83 0.03 0.07 0.77 0.09 0.28 0.12 0.15 0.05 0.02 -4.72 -9.38
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
14 36 45 40 62 65 78 91 109 140 107 0
12 31 38 32 51 62 65 93 100 127 142 0
Operating Profit 2 5 6 7 10 3 12 -2 9 13 -36 -0
OPM % 13% 14% 14% 19% 17% 5% 16% -2% 9% 9% -34% -1,750%
0 -0 0 0 0 -3 1 1 0 2 0 -23
Interest 1 1 2 2 4 5 5 5 5 7 7 1
Depreciation 0 1 1 1 2 1 2 2 4 4 5 0
Profit before tax 1 3 4 4 5 -6 7 -8 1 3 -48 -25
Tax % 37% 34% 30% 37% 39% 28% -13% 21% 84% 35% 0% 3%
1 2 3 2 3 -4 8 -6 0 2 -48 -24
EPS in Rs 1.94 2.61 1.98 2.41 -1.66 2.85 -1.84 0.04 0.64 -14.03 -6.94
Dividend Payout % 0% 0% 0% 0% 0% 0% 8% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: -53%
5 Years: -81%
3 Years: -94%
TTM: -100%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 100%
Stock Price CAGR
10 Years: -10%
5 Years: -34%
3 Years: -5%
1 Year: %
Return on Equity
10 Years: -10%
5 Years: -20%
3 Years: -36%
Last Year: -2%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Equity Capital 4 5 5 6 6 11 13 17 17 17 17 17
Reserves 3 5 8 11 14 31 46 50 50 52 5 -19
8 10 15 22 32 40 72 66 73 75 76 2
4 10 16 16 23 32 35 37 31 25 39 10
Total Liabilities 19 29 44 54 75 114 166 170 172 170 137 9
10 12 19 27 36 23 33 39 72 82 81 0
CWIP 0 1 0 1 1 13 38 48 22 17 13 0
Investments 0 0 2 0 0 4 4 4 4 4 0 0
8 16 22 26 38 73 91 79 74 66 43 9
Total Assets 19 29 44 54 75 114 166 170 172 170 137 9

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
-0 3 8 4 4 -16 -10 20 7 12 9 -14
-3 -3 -11 -8 -11 -5 -34 -19 -11 -10 -3 94
3 1 3 5 7 32 36 -2 4 -3 -8 -80
Net Cash Flow -0 1 0 0 -0 10 -8 -1 -0 -0 -1 -1

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Debtor Days 80 91 99 97 88 75 120 105 84 43 9 19,710
Inventory Days 191 61 82 166 170 134 181 113 111 124 90
Days Payable 127 115 151 187 168 186 190 177 133 76 35
Cash Conversion Cycle 144 37 30 76 89 23 111 41 62 91 64 19,710
Working Capital Days 139 58 40 75 84 174 244 126 113 82 98 -12,228
ROCE % 14% 27% 25% 19% 19% 3% 10% -3% 4% 9% -33% -1%

Shareholding Pattern

Numbers in percentages

Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020
40.07% 40.07% 40.07% 40.07% 40.07% 40.07% 40.07% 40.07% 40.07% 40.07% 40.07% 40.07%
0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03%
59.91% 59.91% 59.91% 59.91% 59.91% 59.90% 59.90% 59.90% 59.91% 59.90% 59.91% 59.91%
No. of Shareholders 8,0887,8787,8427,8167,8287,8437,8117,8057,8177,7507,7247,943

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls

  • Sep 2016
    Transcript
    Notes
    PPT